Volume 73, Issue 3, Pages (March 2018)

Slides:



Advertisements
Similar presentations
Volume 60, Issue 4, Pages (October 2011)
Advertisements

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis  Maria I. Carlo, Darren R.
Global Trends in Testicular Cancer Incidence and Mortality
Volume 70, Issue 6, Pages (December 2016)
The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks  Marcus G.
Renal Cell Carcinoma: Prognostic Factors and Patient Selection
Volume 71, Issue 2, Pages (February 2017)
Volume 61, Issue 5, Pages (May 2012)
Volume 51, Issue 1, Pages (January 2007)
Volume 72, Issue 5, Pages (November 2017)
Volume 69, Issue 1, Pages 4-6 (January 2016)
Volume 54, Issue 4, Pages (October 2008)
Let the Games Begin (with EAU Approval)
Volume 68, Issue 1, Pages (July 2015)
Prostate Cancer Epidemic in Sight?
Giuseppe Di Lorenzo, Riccardo Autorino, Cora N. Sternberg 
Volume 50, Issue 5, Pages (November 2006)
Volume 59, Issue 2, Pages (February 2011)
Volume 63, Issue 1, Pages (January 2013)
Treatment of Advanced and Metastatic Renal Cancer: A Revolution?
Volume 66, Issue 2, Pages (August 2014)
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 54, Issue 4, Pages (October 2008)
Volume 51, Issue 3, Pages (March 2007)
Volume 52, Issue 5, Pages (November 2007)
Volume 71, Issue 3, Pages (March 2017)
Prostate Cancer Detection: A View of the Future
Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma
Next-generation Sequencing of Urologic Cancers: Next Is Now
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 68, Issue 1, Pages (July 2015)
Early Tumour Shrinkage: A Tool for the Detection of Early Clinical Activity in Metastatic Renal Cell Carcinoma  Viktor Grünwald, Xun Lin, Daniel Kalanovic,
Obesity and Prostate Cancer: A Role for Adipokines
Volume 69, Issue 3, Pages (March 2016)
Volume 60, Issue 5, Pages (November 2011)
International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia  Brett Delahunt, John R. Srigley, Lars Egevad,
Prostate Cancer Epidemic in Sight?
Volume 50, Issue 3, Pages (September 2006)
Volume 74, Issue 3, Pages (September 2018)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 66, Issue 5, Pages (November 2014)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Tyrosine Kinase Inhibitors in Clinical Practice: Patient Selection
Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl  European Urology 
Is Simple Enucleation a Minimal Partial Nephrectomy Responding to the EAU Guidelines’ Recommendations?  Vincenzo Ficarra, Antonio Galfano, Stefano Cavalleri 
Volume 50, Issue 5, Pages (November 2006)
Volume 50, Issue 3, Pages (September 2006)
Mammalian Target of Rapamycin Inhibitors in Clinical Practice: Case Reports of Everolimus in Renal Cell Carcinoma  Sergio Bracarda, Alain Ravaud, Marino.
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Testicular Cancer Variations in Time and Space in Europe
Volume 54, Issue 4, Pages (October 2008)
Sergio Bracarda  European Urology Supplements 
European Urology is “Your” Journal
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
Epidemiology of Renal Cell Carcinoma
Volume 51, Issue 6, Pages (June 2007)
Volume 51, Issue 4, Pages (April 2007)
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Economic Burden of Bladder Cancer Across the European Union
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Annika Berntsen, Poul F. Geertsen, Inge Marie Svane  European Urology 
Joaquim Bellmunt  European Urology Supplements 
Jan Roigas  European Urology Supplements 
Update on the Medical Treatment of Metastatic Renal Cell Carcinoma
Volume 51, Issue 5, Pages (May 2007)
Sequencing and Combination of Systemic Therapy in Metastatic Renal Cell Carcinoma  Guillermo de Velasco, Axel Bex, Laurence Albiges, Thomas Powles, Brian.
Presentation transcript:

Volume 73, Issue 3, Pages 311-315 (March 2018) Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer  Thomas Powles, Laurence Albiges, Michael Staehler, Karim Bensalah, Saeed Dabestani, Rachel H. Giles, Fabian Hofmann, Milan Hora, Markus A. Kuczyk, Thomas B. Lam, Lorenzo Marconi, Axel S. Merseburger, Sergio Fernández-Pello, Rana Tahbaz, Alessandro Volpe, Börje Ljungberg, Axel Bex  European Urology  Volume 73, Issue 3, Pages 311-315 (March 2018) DOI: 10.1016/j.eururo.2017.11.016 Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 1 Updated European Association of Urology guideline recommendations for the treatment of first-line metastatic clear-cell renal cancer. IMDC=International Metastatic Renal Cell Carcinoma Database Consortium; VEGF=vascular endothelial growth factor. * Pazopanib for intermediate risk only. European Urology 2018 73, 311-315DOI: (10.1016/j.eururo.2017.11.016) Copyright © 2017 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.